No Picture
News

Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress(TM) 2020

Oral Presentation to Highlight New Efficacy Data Measured at Week 16 and Additional Week 12 Efficacy Data Stratified by Baseline Characteristics and Risk Factors

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKT… […]

No Picture
News

Tarsus Pharmaceuticals Welcomes Aziz Mottiwala as Chief Commercial Officer and Relocates to Larger Irvine Headquarters

Mr. Mottiwala Brings over 20 Years of Biopharmaceutical Experience to Growing Tarsus Leadership Team

ORANGE COUNTY, Calif., Aug. 11, 2020 /PRNewswire/ — Tarsus Pharmaceuticals, a late clinical-stage biopharmaceutical company, today announced the app… […]

No Picture
News

Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CARLSBAD, Calif., Aug. 4, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, wit… […]

No Picture
News

HUYA Bioscience International Licenses the Novel SHP2 Inhibitor HBI-2376 for Development in Oncology

 SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — HUYA Bioscience International (HUYABIO

®
), the leader in accelerating global development of China’s pharmaceutical innovations, announced today it has exclusively licensed worldwide rights, … […]

No Picture
News

Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update

– Advancing Precommercial Activities in Preparation for Phexxi(TM) Commercial Launch in September 2020 — Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea on Track for Q4 2020 Initiation — Management to Host Conference Call Tu… […]

No Picture
News

Microbiologics expands virology capabilities for SARS-CoV-2 with new BSL-3 laboratory at its San Diego facility

SAN DIEGO, Aug. 3, 2020 /PRNewswire/ — Microbiologics announced today that it has recently completed renovations of the virology services laboratory in its San Diego location. With completion of the renovation, Microbiologics has expanded its custo… […]

No Picture
News

Evofem Biosciences’ CEO Saundra Pelletier Named to PharmaVOICE100 – The Most Inspiring People in Life Sciences

SAN DIEGO, Aug. 3, 2020 /PRNewswire/ — Evofem Biosciences, Inc. (NASDAQ: EVFM) is proud to announce that CEO Saundra Pelletier was named to the PharmaVOICE 100 Most Inspiring People, an annual list of the 100 most innovative, influential and inspir… […]

No Picture
News

Qualigen Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CARLSBAD, Calif., Aug. 2, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced it has entered into a definitive agreement with a single institutional investor for the purchase and sale for $1… […]

No Picture
News

Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment

Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative

SAN DIEGO, July 31, 2020 /PRNewswire/ — Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases dia… […]

No Picture
News

Mesa Biotech to Receive up to $15.4 Million Funding from the National Institutes of Health for Accelerated Scale-up and Deployment

Mesa Biotech Among the First Selected for NIH’s Rapid Acceleration of Diagnostics Initiative

SAN DIEGO, July 31, 2020 /PRNewswire/ — Mesa Biotech, developers of an affordable, easy to use, handheld testing platform for infectious diseases dia… […]

No Picture
News

Viking Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update

Conference call scheduled for 4:30 p.m. ET today- Enrollment Continues in Phase 2b VOYAGE Study of VK2809 in NASH; New Data from 12-Week Phase 2 Trial to be Highlighted at EASL- IND Filed for VK0214 in X-ALD; Phase 1 Trial Expected to Begin Q3 2020- Ba… […]

No Picture
News

Regulus Therapeutics Announces FDA Orphan Drug Designation of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

LA JOLLA, Calif., July 29, 2020 /PRNewswire/ — Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the “Company” or “Regulus”), today announced … […]

No Picture
News

Heritage Global Partners and Federal Equipment Company to Conduct Major Auction of Veterinary Biologics/Vaccine Manufacturing Site Online Auction Features State of the Art Processing and Lab Equipment

August 19, 2020 – August 20, 2020https://www.hgpauction.com/auctions/104084/vos/
SAN DIEGO, CALIF., July 28, 2020 /PRNewswire/ – Heritage Global Partners (“HGP”), a worldwide leader in asset advisory and auction services, in conjunction with Fede… […]

No Picture
News

Mindera Corporation Announces Appointment of George W. Mahaffey as President and Chief Executive Officer

SAN DIEGO, July 27, 2020 /PRNewswire/ — Mindera Corporation has announced that George W. Mahaffey was appointed President and Chief Executive Officer, and will also serve as a Director of the Company.

Treatment of chronic skin conditions is … […]

No Picture
News

MetVital, Inc. Announces Collaboration with the National Institute of Neurological Disorders and Stroke (part of the NIH) in the Epilepsy Therapy Screening Program (ETSP)

SAN DIEGO, July 24, 2020 /PRNewswire/ — MetVital, Inc., a privately held biopharmaceutical company developing small molecule modulators of altered glutamate metabolism for the treatment of diseases with significant unmet medical need and commercial… […]

No Picture
News

Exonbio launches high affinity SARS-CoV-2 rabbit monoclonal antibodies to accelerate the global IVD and research community efforts

SAN DIEGO, July 23, 2020 /PRNewswire/ — Exonbio, a leading recombinant antibody CRO company now launches the SARS-CoV-2 Nucleocapsid recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the p… […]

No Picture
News

Qualigen Therapeutics Signs Exclusive License Agreement with the University of Louisville for RAS Interaction Inhibitor Drug Candidates

RAS is the most common oncogene implicated in human cancerKRAS, HRAS or NRAS mutations are present in approximately one-third of all cancer patients

CARLSBAD, Calif. , July 22, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen… […]

No Picture
News

Amplyx Announces Positive Top-line Data in Phase 2 Clinical Trial of Novel Antifungal Fosmanogepix

Fosmanogepix met primary efficacy endpoint and demonstrated favorable safety profile in first-line treatment of invasive Candida infections

SAN DIEGO, July 20, 2020 /PRNewswire/ — Amplyx Pharmaceuticals, a clinical-stage biopharmaceutical company de… […]